These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37896130)

  • 21. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
    Kim SH; Lee SD; Kim YK; Park SJ
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients.
    Seibert SR; Schladt DP; Wu B; Guan W; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
    Clin Transplant; 2018 Dec; 32(12):e13424. PubMed ID: 30318646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.
    Trofe-Clark J; Brennan DC; West-Thielke P; Milone MC; Lim MA; Neubauer R; Nigro V; Bloom RD
    Am J Kidney Dis; 2018 Mar; 71(3):315-326. PubMed ID: 29162334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring intracellular tacrolimus concentrations and its relationship with rejection in the early phase after renal transplantation.
    Francke MI; Andrews LM; Lan Le H; van de Velde D; Dieterich M; Udomkarnjananun S; Clahsen-van Groningen MC; Baan CC; van Gelder T; de Winter BCM; Hesselink DA
    Clin Biochem; 2022 Mar; 101():9-15. PubMed ID: 34890583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up.
    Spagnoletti G; Gargiulo A; Salerno MP; Favi E; Pedroso JA; Calia R; Romagnoli J; Citterio F
    Transplant Proc; 2014 Sep; 46(7):2224-7. PubMed ID: 25242756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
    Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko M; Wiesner RH; Krom RA
    Transplantation; 1996 Dec; 62(11):1588-92. PubMed ID: 8970613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Formulation of Fusidic Acid Incorporated into a Myrrh-Oil-Based Nanoemulgel for the Enhancement of Skin Bacterial Infection Treatment.
    Almostafa MM; Elsewedy HS; Shehata TM; Soliman WE
    Gels; 2022 Apr; 8(4):. PubMed ID: 35448146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrolimus time-in-therapeutic range is associated with freedom from acute rejection and graft failure following intestinal transplantation.
    Santeusanio AD; Gu A; Weinberg AD; Moon J; Iyer KR
    Clin Transplant; 2021 Jun; 35(6):e14291. PubMed ID: 33740822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses.
    Ferraris JR; Tambutti ML; Cardoni RL; Prigoshin N
    Transplantation; 2004 Feb; 77(4):532-7. PubMed ID: 15084930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and safety of the conversion to MeltDose
    Sánchez Fructuoso A; Ruiz JC; Franco A; Diekmann F; Redondo D; Calviño J; Serra N; Aladrén MJ; Cigarrán S; Manonelles A; Ramos A; Gómez G; González Posada JM; Andrés A; Beneyto I; Muñiz AL; Perelló M; Lauzurica R
    Clin Transplant; 2020 Jan; 34(1):e13767. PubMed ID: 31815310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation.
    Gerlach UA; Klöpfel M; Atanasov G; Polenz D; Vogt K; Ahrlich S; Marksteiner M; Jurisch A; Loddenkemper C; Reutzel-Selke A; Sawitzki B; Pascher A
    Transplantation; 2017 May; 101(5):1036-1045. PubMed ID: 27607529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function.
    Han SS; Yang SH; Kim MC; Cho JY; Min SI; Lee JP; Kim DK; Ha J; Kim YS
    PLoS One; 2016; 11(4):e0153491. PubMed ID: 27082871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, characterization and evaluation of anti-inflammatory and anti-nociceptive effects of brucine-loaded nanoemulgel.
    Abdallah MH; Abu Lila AS; Unissa R; Elsewedy HS; Elghamry HA; Soliman MS
    Colloids Surf B Biointerfaces; 2021 Sep; 205():111868. PubMed ID: 34034223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients.
    Jung HY; Seo MY; Jeon Y; Huh KH; Park JB; Jung CW; Lee S; Han SY; Ro H; Yang J; Ahn C; Choi JY; Cho JH; Park SH; Kim YL; Kim CD
    PLoS One; 2020; 15(7):e0235418. PubMed ID: 32614859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.
    Uemoto S; Abe R; Horike H; So M
    Transplant Proc; 2014 Apr; 46(3):749-53. PubMed ID: 24767340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-Delivery of Imiquimod and Curcumin by Nanoemugel for Improved Topical Delivery and Reduced Psoriasis-Like Skin Lesions.
    Algahtani MS; Ahmad MZ; Nourein IH; Ahmad J
    Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32605030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
    McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
    Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients.
    Francke MI; Hesselink DA; Li Y; Koch BCP; de Wit LEA; van Schaik RHN; Yang L; Baan CC; van Gelder T; de Winter BCM
    Br J Clin Pharmacol; 2021 Apr; 87(4):1918-1929. PubMed ID: 33025649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis.
    Srivastava M; Kohli K; Ali M
    Drug Deliv; 2016; 23(1):154-66. PubMed ID: 24786482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.